IPCA Laboratories Limited — Board Meeting, 11-08-2025: Outcome of Board Meeting

Ipca Laboratories has announced a board meeting where it approved the financial results for the quarter ending June 30, 2025. Consolidated Net Total Income grew 11% to ₹2,341.51 Cr. Consolidated Net Profit jumped 18% to ₹234.42 Cr, with EPS rising 21% to ₹9.19. The company also acquired 100% equity in Unichem Laboratories, Ireland, making it a wholly-owned subsidiary, a strategic move for future growth.